Factors affecting accuracy of S values and determination of time-integrated activity in clinical Lu-177 dosimetry.


Journal

Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 04 03 2019
accepted: 16 04 2019
pubmed: 24 5 2019
medline: 18 12 2019
entrez: 24 5 2019
Statut: ppublish

Résumé

In any radiotherapy, the absorbed dose needs to be estimated based on two factors, the time-integrated activity of the administered radiopharmaceutical and the patient-specific dose kernel. In this study, we consider the uncertainty with which such absorbed dose estimation can be achieved in a clinical environment. To calculate the total error of dose estimation we considered the following aspects: The error resulting from computing the time-integrated activity, the difference between the S-value and the patient specific full Monte Carlo simulation, the error from segmenting the volume-of-interest (kidney) and the intrinsic error of the activimeter. The total relative error in dose estimation can amount to 25.0% and is composed of the error of the time-integrated activity 17.1%, the error of the S-value 16.7%, the segmentation error 5.4% and the activimeter accuracy 5.0%. Errors from estimating the time-integrated activity and approximations applied to dose kernel computations contribute about equally and represent the dominant contributions far exceeding the contributions from VOI segmentation and activimeter accuracy.

Identifiants

pubmed: 31119607
doi: 10.1007/s12149-019-01365-6
pii: 10.1007/s12149-019-01365-6
doi:

Substances chimiques

Radioisotopes 0
Lutetium 5H0DOZ21UJ
Lutetium-177 BRH40Y9V1Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-531

Auteurs

Th I Götz (TI)

Department of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany. theresa.goetz@biologie.uni-regensburg.de.
CIML Group, Biophysics, University of Regensburg, 93040, Regensburg, Germany. theresa.goetz@biologie.uni-regensburg.de.
Pattern Recognition Lab, University of Erlangen-Nürnberg, 91058, Erlangen, Germany. theresa.goetz@biologie.uni-regensburg.de.

C Schmidkonz (C)

Department of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.

E W Lang (EW)

CIML Group, Biophysics, University of Regensburg, 93040, Regensburg, Germany.

A Maier (A)

Pattern Recognition Lab, University of Erlangen-Nürnberg, 91058, Erlangen, Germany.

T Kuwert (T)

Department of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.

P Ritt (P)

Department of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH